Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Icahn School of Medicine at Mount Sinai · University of Bern · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
638
total citations
- FWCI
- 35.01
- Percentile
- 100%
- References
- 164
Citations per year
Authors
4Topics & keywords
Topics
Keywords
- Sorafenib
- Medicine
- Clinical trial
- Hepatocellular carcinoma
- Disease
- Drug development
- Targeted therapy
- Intensive care medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.